Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
Abroad (travel likely)RecruitingPHASE1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Recurrent High Grade Glioma
Locations
- Memorial Sloan Kettering, New York, New York, United States
- Duke University, Durham, North Carolina, United States